Genzyme Corporation H1B salary
105 certified LCAs · FY2022–FY2026
- Certified filings
- 105
- Avg wage
- $140,407
- Median wage
- $125,250
- Active years
- FY2022–FY2026
Wage level distribution
Filings — last 8 quarters
Top H1B job titles at Genzyme Corporation
Recent certified records
| Job Title↕ | Wage (annual)↕ | Level | Location | FY/Q▼ | Status |
|---|---|---|---|---|---|
| Systems Support Manager | $126,243 | N/A | Cambridge, MA | Q2 FY2026 | Certified |
| Associate Director, Forecasting Rare Blood Disorders | $148,500 | Level III | Cambridge, MA | Q2 FY2026 | Certified |
| Global Head of Hematology (Medical Affairs) | $290,000 | Level IV | Cambridge, MA | Q2 FY2026 | Certified |
| Associate Director, Cross-Portfolio Analytics – Vaccines | $125,250 | Level II | Morristown, NJ | Q2 FY2026 | Certified |
| Assoc. Director, DUPIXENT Payer Analytics and Insights Lead | $147,000 | Level IV | Jersey City, NJ | Q2 FY2026 | Certified |
| Director, Global Hemophilia Marketing | $240,053 | Level IV | Cambridge, MA | Q4 FY2025 | Certified |
| Director, National Accounts, Medical Value and Outcomes | $203,154 | Level IV | Cambridge, MA | Q4 FY2025 | Certified |
| Senior Manager, Advanced Analytics | $148,762 | Level IV | Cambridge, MA | Q4 FY2025 | Certified |
| Associate Marketing Director, Dermatology Patient Marketing | $140,625 | Level III | Cambridge, MA | Q4 FY2025 | Certified |
| Senior Global Medical Lead | $225,000 | Level IV | Cambridge, MA | Q4 FY2025 | Certified |
| AI Systems & ML Scientist | $113,464 | Level III | Framingham, MA | Q4 FY2025 | Certified |
| Associate Director, Strategy and Ops, Global Immunology | $147,000 | N/A | Cambridge, MA | Q4 FY2025 | Certified |
| Global Market Data Senior Manager | $111,966 | Level II | Morristown, NJ | Q3 FY2025 | Certified |
| Scientist | $107,099 | Level II | Cambridge, MA | Q3 FY2025 | Certified |
| Pharmacovigilance Quality Management System Expert | $133,025 | N/A | Cambridge, MA | Q3 FY2025 | Certified |
| Supervisor, Inspection & Packaging | $91,894 | Level II | Ridgefield, NJ | Q3 FY2025 | Certified |
| Senior Associate Scientist | $73,500 | Level I | Waltham, MA | Q3 FY2025 | Certified |
| Senior Medical Program Manager - Pulmonology | $203,154 | Level IV | Cambridge, MA | Q3 FY2025 | Certified |
| Engineer II | $74,250 | Level I | Ridgefield, NJ | Q3 FY2025 | Certified |
| Global Scientific Communications Lead - Rare Disease | $165,568 | Level III | Los Angeles, CA | Q3 FY2025 | Certified |
| Senior Manager, Forecasting | $111,966 | Level II | Morristown, NJ | Q3 FY2025 | Certified |
| Data Historian (OSI PI) Engineer III | $124,259 | Level III | Framingham, MA | Q2 FY2025 | Certified |
| Global Customer Engagement Lead | $201,000 | Level IV | Cambridge, MA | Q2 FY2025 | Certified |
| Data Historian (OSI PI) Engineer III | $124,259 | Level III | Framingham, MA | Q2 FY2025 | Certified |
| Head of Global Immunology Franchise | $325,000 | Level IV | Cambridge, MA | Q2 FY2025 | Certified |
PERM green card filings
Unlock Genzyme Corporation's PERM history
Sign in with a free account to see full PERM green card filing data — counts, roles, wages, and outcomes — for every company.
Sign in to unlockDoes Genzyme Corporation sponsor H1B?
›Does Genzyme Corporation sponsor H1B?
Based on 105 certified LCAs filed in FY2022–FY2026, Genzyme Corporation has an established history of H1B-related labor condition applications with DOL. An LCA is a labor condition application certified by DOL; it does not by itself constitute an approved H-1B petition or an employment offer, and past filings do not guarantee future sponsorship.
›What does Genzyme Corporation pay H1B workers?
Across certified LCA filings, Genzyme Corporation's average offered wage is $140,407 (median $125,250). Actual pay varies by role, level, and work location — see the records below.
›Where does Genzyme Corporation file H1B LCAs?
The most frequent work location on record is Cambridge, MA (72 certified filings).
Related companies
Records shown are certified LCAs from DOL OFLC disclosure files for Genzyme Corporation.